A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus

An increased prevalence of the metabolic syndrome has been found in patients with systemic lupus erythematosus in recent years.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metabolic Syndrome Autoimmune Diseases Cardiovascular Risk Factors Connective Tissue Diseases Glucose Metabolism Disorders Hyperinsulinism Immune System Diseases Insulin Resistance Lupus Erythematosus, Systemic Metabolic Diseases Nutritional and Metabolic Diseases Skin and Connective Tissue Diseases Systemic Lupus Erythematosus

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Far Eastern Memorial Hospital

Pan-Chiao, Taipei, Taiwan

About this study

This study will investigate the prevalence of the metabolic syndrome in patients with SLE in Taiwan. We expect our study will provide further understanding of the association between SLE and metabolic syndrome, which may give direction to prevent late cardiovascular morbidity and mortality in SLE patients.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Persons aged 18 and above.
Persons fulfill the diagnostic criteria of the 1997 American College of Rheumatology for systemic lupus erythematosus in the patient group.

Exclusion criteria

Exclude a history myocardial infarction, angina or stroke.

Treatment and study plan

Primary outcomes

The prevalence of the metabolic syndrome in patients with systemic lupus erythematosus in Taiwan

Time frame: One year

Sponsors and collaborators

Lead sponsor

Far Eastern Memorial Hospital

Other

Registry information

Official study title

Association of the Metabolic Syndrome and Systemic Lupus Erythematosus in Taiwan

Important dates

Study start: 2008
Primary completion: 2008
Study completion: 2009
First posted: Sep 23, 2009
Registry last updated: Sep 23, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed